引用本文:蒙冠云.百令胶囊与胰激肽原酶联合治疗早期糖尿病肾病的临床观察[J].中国临床新医学,2010,3(8):739-741.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1774次   下载 1264 本文二维码信息
码上扫一扫!
分享到: 微信 更多
百令胶囊与胰激肽原酶联合治疗早期糖尿病肾病的临床观察
蒙冠云
530003 南宁,武警广西边防总队医院
摘要:
[摘要] 目的 观察百令胶囊与胰激肽原酶联合治疗早期糖尿病肾病(EDN)的疗效以及治疗前后尿微量白蛋白的变化。方法 将50例早期EDN患者随机分为两组,对照组在常规治疗基础上予胰激肽原酶240 U,3次/d,口服;联合治疗组在对照组基础上加用百令胶囊1.0 g,3次/d,口服,12周和6个月后观察联合治疗组与对照组治疗前后24 h尿微量白蛋白排泄率(UAER)的变化。结果 治疗后12周,两组患者治疗前后24 h UAER均有较明显下降(P<0.05);治疗后6个月,对照组患者治疗前后24 h UAER有一定的下降(P<0.05),联合组患者治疗前后24 h UAER有明显的下降(P<0.01);治疗后12周和6个月组间比较,联合组24 h UAER与对照组比较差异有统计学意义(P<0.05)。结论 百令胶囊与胰激肽原酶联合应用能明显降低EDN患者的尿微量白蛋白排泄,可以有效延缓DN的进展。
关键词:  早期糖尿病肾病  24 h尿微量白蛋白排泄率  百令胶囊  胰激肽原酶
DOI:10.3969/j.issn.1674-3806.2010.08.15
分类号:R 587.2
基金项目:
Therapeutic efficacy of bailing capsule combined with pancreatic kininogenase in the treament of early diabetic nephropathy
MENG Guan-yun
Armed Police Corps Hospital of Guangxi Border,Nanning 530003,China
Abstract:
[Abstract] Objective To observe the therapeutic efficacy of bailing capsule combined with pancreatic kininogenase(PK) in the treatment of early diabetic nephropathy (EDN), and the changes of urinary micro-albumin. Methods Fifty cases of EDN were randomly divided into two groups.On the bases of routine therapy, the comparison group took PK 240 U, 3 times a day orally. On the basis of the comparison group, the combined treatment group took bailing capsule 1.0 g, 3 times a day orally. The changes of 24 h urinary albumin excretion rate(UAER) in the combined treatment group and the comparison group were observed before and after 12 weeks or 6 months of treatment. Results The 24h UAER of the two groups were all decreased (P<0.05) after 12 weeks;after 6 months, the 24 h UAER of the comparison group were decreased (P<0.05), and that of the combined treatment group decreased more significantly (P<0.01); there was significant difference between the two groups after 12 weeks or 6 months of treatment (P<0.05). Conclusion Bailing capsule combined with PK could significantly reduced urinary micro-albumin excretion of EDN patients and effectively delay the progress of DN.
Key words:  Early diabetic nephropathy  24 h urinary albumin excretion rate  Bailing capsule  Pancreatic kininogenase